CAPRICOR THERAPEUTICS, INC. Public Float
CAPRICOR THERAPEUTICS, INC. (CAPR) had Public Float of $398.99 million as of 2025-06-30, per its 10-K filed 2026-03-17.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-17
- 2025-06-30: Entity Public Float $398.99M.
- 2024-06-30: Entity Public Float $140.05M.
- 2023-06-30: Entity Public Float $119.72M.
- 2022-06-30: Entity Public Float $82.67M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $398.99M 10-K · filed 2026-03-17 |
| 2024-06-30 | $140.05M 10-K · filed 2025-03-26 |
| 2023-06-30 | $119.72M 10-K · filed 2024-03-11 |
| 2022-06-30 | $82.67M 10-K · filed 2023-03-17 |
| 2021-06-30 | $115.33M 10-K · filed 2022-03-11 |
| 2020-06-30 | $86.53M 10-K · filed 2021-03-15 |
| 2019-06-30 | $8.77M 10-K · filed 2020-03-27 |
| 2018-06-30 | $29.04M 10-K · filed 2019-03-29 |
| 2017-06-30 | $9.56M 10-K · filed 2018-03-22 |
| 2016-06-30 | $32.57M 10-K · filed 2017-03-16 |
| 2015-06-30 | $32.45M 10-K · filed 2016-03-30 |
| 2014-06-30 | $13.68M 10-K · filed 2015-03-16 |
| 2013-06-30 | $1.70M 10-K · filed 2014-03-31 |
| 2012-06-30 | $3.76M 10-K · filed 2013-06-21 |
| 2011-06-30 | $21.73M 10-K · filed 2012-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |